MONROVIA, Calif--Refractive-surgery firm Staar Surgical (Nasdaq: STAA) has entered into a definitive agreement to sell 4.1 million shares of newly issued common stock at $3.50 per share to certain institutional investors. The transaction was expected to be completed on or about April 5, subject to customary closing conditions, the company said.